We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Commentary · December 30, 2019

Should Interventional Pulmonologists Take Ownership for Ordering NGS and Immunohistochemistries for Patients With Newly Diagnosed NSCLC?

Chest

 

Additional Info

Disclosure statements are available on the authors' profiles:

Chest
Should Interventional Pulmonologists Take Ownership for Ordering Next-Generation Sequencing and Immunohistochemistries for Patients With Newly Diagnosed Non-Small Cell Lung Cancer?
Chest 2019 Dec 01;156(6)1281-1282, AK Mahajan, E Folch, A Musani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading